This work studied the correlations between survivin, bcl-2 and p53 in infiltrating ductal carcinoma of the breast. A total number of 382 cases were collected from 3 hospitals in northeastern Malaysia. Survivin, bcl-2 and p53 were detected by immunohistochemistry on samples prepared from tissue blocks. Significant correlations were found between tumor histological grades and tumor size and lymph node involvement. Highly significant statistical correlations (p<0.001) were found in expression of the markers under study. It is concluded that such significant correlations may imply that the alterations in the expression take place in a concerted fashion, implying that many of these cases may share common abnormalities.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Preliminary evidence of immune infiltration and neutrophil degranulation in peripheral blood of non-obese OSA patients related to cognitive decline.
Sci Rep
January 2025
Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Obstructive sleep apnea (OSA) patients have varying degrees of cognitive impairment, but the specific pathogenic mechanism is still unclear. Meanwhile, poor compliance with continuous positive airway pressure (CPAP) in OSA prompts better solutions. This study aimed to identify differentially expressed genes between the non-obese OSA patients and healthy controls, and to explore potential biomarkers associated with cognitive impairment.
View Article and Find Full Text PDFBackground: The pathogenesis of colorectal cancer (CRC) is influenced by various risk factors, and genetic alterations in progression of colon polyps. The expression patterns of microRNA-548 (miR-548) in colorectal tissues have been sufficiently characterized. The aim of this study is to clarify the role of miR-548aa in tumorigenesis, gene targeting, predictive value and its expression levels in tumoral versus adjacent marginal tissues in CRC patients.
View Article and Find Full Text PDFBIRC5 as a prognostic and diagnostic biomarker in pan-cancer: an integrated analysis of expression, immune subtypes, and functional networks.
Front Genet
December 2024
School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Article Synopsis
- BIRC5 (Survivin) is an anti-apoptotic protein found to be overexpressed in 33 different types of cancer, leading to increased tumor growth and resistance to treatment.
- The study utilized RNA-seq and protein expression data to assess BIRC5 levels in tumor versus normal tissues, revealing strong correlations between its expression and various cancer subtypes, along with a significant association with poor patient prognosis.
- The research highlights BIRC5's potential as a diagnostic and prognostic biomarker, as well as a therapeutic target due to its impact on cell proliferation and interaction with the immune microenvironment.
BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism.
Lymphatics
June 2024
The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY 11030, USA.
CLL B cells express elevated pro-survival BCL2, and its selective inhibitor, venetoclax, significantly reduces leukemic cell load, leading to clinical remission. Nonetheless, relapses occur. This study evaluates the hypothesis that progressively diminished BCL2 protein in cycling CLL cells within patient lymph node niches contributes to relapse.
View Article and Find Full Text PDFVitamin D receptor and its antiproliferative effect in human pulmonary arterial hypertension.
Sci Rep
November 2024
Department of Pharmacology and Toxicology, Facultad de Medicina, School of Medicine, Universidad Complutense de Madrid, Pza Ramón y Cajal s/n., 28040, Madrid, Spain.
Article Synopsis
- Vitamin D deficiency in pulmonary arterial hypertension (PAH) patients is linked to a poorer prognosis, and this study investigates the role of the vitamin D receptor (VDR) in the pulmonary vasculature.
- VDR is found in pulmonary artery smooth muscle cells (PASMC), and its expression is lower in PAH patients compared to non-hypertensive controls, but can be increased by calcitriol treatment.
- Calcitriol not only raises VDR expression but also has an antiproliferative effect on PASMC, which involves the modulation of specific genes like survivin and BMP signaling, suggesting potential therapeutic implications for PAH.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!